Journal
TRENDS IN CANCER
Volume 3, Issue 5, Pages 347-356Publisher
CELL PRESS
DOI: 10.1016/j.trecan.2017.03.007
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA193842, R01 CA168654] Funding Source: Medline
- NIDDK NIH HHS [K01 DK084261, R01 DK101989] Funding Source: Medline
Ask authors/readers for more resources
The mammalian MSI family of RNA-binding proteins (RBPs) have important roles as oncoproteins in an array of tumor types, including leukemias, glioblastomas, and pancreatic, breast, lung, and colorectal cancers. The mammalian Msi genes, Msi1 and Msi2, have been most thoroughly investigated in two highly proliferative tissues prone to oncogenic transformation: the hematopoietic lineage and the intestinal epithelium. Despite their vast phenotypic differences, MSI proteins appear to have an analogous role in governing the stem cell compartment in both of these tissues, potentially providing a paradigm for a broader understanding of MSI function and oncogenic activities. In this review, we focus on the function of MSI in the blood and the intestine, and discuss therapeutic strategies for targeting this pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available